tiprankstipranks
Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
US Market
IDXG
Interpace Diagnostics Group
RESEARCH TOOLSreports

Interpace Diagnostics Group (IDXG) Financial Statements

413 Followers

Interpace Diagnostics Group Financial Overview

Interpace Diagnostics Group's market cap is currently $55.26M. The company's EPS TTM is $0.818; its P/E ratio is 0.06; Interpace Diagnostics Group is scheduled to report earnings on March 30, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 38.73M$ 46.93M$ 40.21M$ 31.84M$ 41.31M
Gross Profit$ 24.13M$ 29.93M$ 23.90M$ 18.23M$ 17.95M
Operating Income$ 4.08M$ 8.11M$ 2.80M$ -3.84M$ -11.74M
EBITDA$ 4.76M$ 8.36M$ 3.84M$ -2.27M$ -1.33M
Net Income$ 24.57M$ 6.70M$ 802.00K$ -5.87M$ -14.75M
Balance Sheet
Cash & Short-Term Investments$ 2.50M$ 1.46M$ 3.50M$ 4.83M$ 3.31M
Total Assets$ 33.84M$ 14.79M$ 13.02M$ 15.98M$ 38.43M
Total Debt$ 1.18M$ 5.86M$ 11.19M$ 16.09M$ 13.72M
Net Debt$ -1.32M$ 4.39M$ 7.69M$ 11.26M$ 10.40M
Total Liabilities$ 11.47M$ 17.01M$ 28.16M$ 79.05M$ 80.84M
Stockholders' Equity$ 22.36M$ -2.22M$ -15.14M$ -63.07M$ -42.42M
Cash Flow
Free Cash Flow$ 5.47M$ 3.77M$ 3.32M$ -8.01M$ -9.07M
Operating Cash Flow$ 5.83M$ 4.65M$ 3.79M$ -7.69M$ -8.72M
Investing Cash Flow$ -356.00K$ -876.00K$ -87.00K$ 6.21M$ -315.00K
Financing Cash Flow$ -4.43M$ -5.81M$ -5.03M$ 3.00M$ 8.98M
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

Income Statement >

Interpace Diagnostics Group Debt to Assets

Balance Sheet >

Interpace Diagnostics Group Cash Flow

Cash Flow >

Interpace Diagnostics Group Forecast EPS vs Actual EPS

Earnings >